Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 706 AL 720

Exploring the Role of microRNAs as Blood Biomarkers in Alzheimer's Disease and Frontotemporal Dementia

Petracci I, Bellini S, Goljanek-Whysall K, Quinlan LR, Fiszer A, Cakmak A, Njume CM, Borroni B, Ghidoni R.

Int J Mol Sci. 2025 Apr 5;26(7):3399. doi: 10.3390/ijms26073399.

Transthyretin as a therapeutic target: the future of disease-modifying therapies for Alzheimer's disease

Shaw S, Porel P, Aran KR.

Mol Biol Rep. 2025 Apr 8;52(1):370. doi: 10.1007/s11033-025-10485-4.

Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease

López-Martos D, Suárez-Calvet M, Milà-Alomà M, Gispert JD, Salvadó G, Brugulat-Serrat A, Shekari M, Minguillon C, Zetterberg H, Blennow K, Grau-Rivera O, Sánchez-Benavides G; ALFA study.

Neurology. 2025 Nov 11;105(9):e214308. doi: 10.1212/WNL.0000000000214308. Epub 2025 Oct 17.

Identification of potential therapeutic targets for Alzheimer's disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study

Wang S, Xi J, Zhang M, Wang J.

Int J Biol Macromol. 2025 Mar;294:139394. doi: 10.1016/j.ijbiomac.2024.139394. Epub 2025 Jan 3.

Advances in Diagnostic Approaches for Alzheimer's Disease: From Biomarkers to Deep Learning Technology

Asif M, Ullah H, Jamil N, Riaz M, Zain M, Pushparaj PN, Rasool M.

CNS Neurol Disord Drug Targets. 2025;24(12):872-881. doi: 10.2174/0118715273374284250519053646.

The Biomarker Profile of Alzheimer's Disease for Disease-Modifying Treatment Eligibility: Questions and Debates

Athanasaki A, Tsantzali I, Theodorou A, Michalopoulou A, Constantinides VC, Boufidou F, Tzartos JS, Tsalouchidou PE, Zompola C, Paraskevas SG, Bonakis A, Giannopoulos S, Tsivgoulis G, Kapaki E, Paraskevas GP.

Int J Mol Sci. 2025 Sep 29;26(19):9531. doi: 10.3390/ijms26199531.

The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia

Russo AP, Pastorello Y, Dénes L, Brînzaniuc K, Krupinski J, Slevin M.

Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.

Unlocking the Future of Alzheimer's Disease: Innovations in Diagnosis and Therapy

Mehndiratta MM, Singla M, Dixit A.

J Assoc Physicians India. 2025 Aug;73(8):92-97. doi: 10.59556/japi.73.1075.

The impact of real-world evidence in implementing and optimizing Alzheimer's disease care

Hampel H, Li G, Mielke MM, Galvin JE, Kivipelto M, Santarnecchi E, Babiloni C, Devanarayan V, Tkatch R, Hu Y, Kurzman R, Cho M, Vandercappellen J, Nakamura Y, Bell J, Mattke S, Toschi N.

Med. 2025 May 9;6(5):100695. doi: 10.1016/j.medj.2025.100695.

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease

Yim S, Gu Y, Kang H, Shin D, Jang H, Yoo H, Zetterberg H, Blennow K, Gonzalez-Ortiz F, Ashton NJ, Weiner MW, Day TA, Lee EH, Na DL, Kim HJ, Kang SH, Kim KW, Kim YJ, Kim Y, Kim J, Chun MY, Jung NY, Cho SH, Kim JP, Yun J, Seo SW; K-ROAD study groups.

Clin Nucl Med. 2025 Dec 1;50(12):1120-1129. doi: 10.1097/RLU.0000000000006088. Epub 2025 Sep 1.

Tracking electrophysiological signatures of Alzheimer's disease: a systematic review of multimodal studies

Sohrabpour A, Sarovic D, Zetterberg H, Hämäläinen MS, Baillet S, Khan S.

Alzheimers Dement. 2025 Nov;21(11):e70835. doi: 10.1002/alz.70835.

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia-specific perspectives

Iwatsubo T, Sperling RA, Algeciras-Schimnich A, Arai H, Barron AM, Benzinger TLS, Carrillo MC, Chen C, Choi SH, Fontana IC, Graff-Radford J, Grill JD, Heidebrink J, Hu CJ, Ihara R, Ikeuchi T, Iwata A, Ip FCF, Fitri FI, Jack CR Jr, Jeong JH, Jia J, Kandiah N, Kim S, Kowa H, La Joie R, Niimi Y, Noritake R, Okonkwo OC, Palmqvist S, Rafii MS, Raman R, Shen Y, Simuni T, Snyder HM, Sriwannopas O, Stoeckel LE, van der Flier WM, Wang H, Wilcock DM, Zetterberg H, Zhou J, Mahinrad S, Sexton CE.

Alzheimers Dement. 2025 Aug;21(8):e70536. doi: 10.1002/alz.70536.

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease

Garbarino VR, Palavicini JP, Melendez J, Barthelemy NR, He Y, Kautz TF, Lopez-Cruzan M, Mathews JJ, Xu P, Zhang B, Saliba A, Ragi N, Sharma K, Mason D, Johnson S, Hendrix S, Craft S, Petersen RC, Espindola-Netto JM, Xue A, Tchkonia T, Kirkland JL, Salardini A, Musi N, Bateman RJ, Gonzales MM, Orr ME.

Neurotherapeutics. 2025 Jul;22(4):e00591. doi: 10.1016/j.neurot.2025.e00591. Epub 2025 Apr 23.

Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications

Akash A, Ahamed M, Porel P, Aran KR.

Brain Res. 2025 Nov 15;1867:149949. doi: 10.1016/j.brainres.2025.149949. Epub 2025 Sep 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias